Attovia Therapeutics, Inc. ATTO
15.32 USD +0.05 (+0.33%)
Nov 4, 2026, 10:08 AM EST
15.27 Day range 15.78
13.73 52-week range 25.55
- YTD
- -30.05%
- 1 year
- -30.05%
Financial health
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -15.4×
FY 2024 5y median -18.1× FY 2025
P/S 698×
FY 2024 5y median 349× FY 2025
P/B 6.2×
FY 2024 5y median 10.7× FY 2025
P/FCF -15.3×
FY 2024 5y median -20.5× FY 2025
EV/EBITDA -13.7×
FY 2024 5y median -17.9× FY 2025
EV/Sales 672×
FY 2024 5y median 336× FY 2025
FCF Yield -6.5%
FY 2024 5y median -5.2% FY 2025
Profitability
Gross Margin 40.4%
FY 2024 5y median 20.2% FY 2025
Operating Margin -4974.7%
FY 2024 5y median -2487.4% FY 2025
Net Margin -4490.9%
FY 2024 5y median -2245.4% FY 2025
ROE -40.2%
FY 2024 5y median -52.1% FY 2025
ROIC -42.8%
FY 2024 5y median -51.5% FY 2025
ROA -36.5%
FY 2024 5y median -44.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income -61.6%
FY 2024 FY 2025
EPS (diluted) -35.2%
FY 2024 FY 2025
Free Cash Flow -67.1%
FY 2024 FY 2025
Financial Health
Current Ratio 14.2×
FY 2024 5y median 11.8× FY 2025
Quick Ratio 14.2×
FY 2024 5y median 11.8× FY 2025
Debt / Equity 0.0×
FY 2024 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2024 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31